Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
CD133 expression in colorectal adenomas
CD133-2分子在急性白血病患者骨髓单个核细胞中的表达及其临床意义
CD133~+细胞在乳腺良恶性病变中的分布特点及其临床病理意义
CD133、Nestin在成年SD大鼠室管膜下区的表达
CD137L在喉癌中的表达及其临床病理学意义
CD133、Ki-67在胃癌的表达及临床病理意义
CD133~+CXCR4~+胃癌KATO-Ⅲ细胞的侵袭能力
CD133在甲状腺乳头状癌中的表达及其与细胞外信号调节激酶1表达的关系
CD13与高血压关系的研究进展
CD133 CD10在子宫内膜息肉中的表达
CD133对前列腺癌恶性潜能的影响
CD133表达对肝癌细胞株HepG2索拉非尼化疗敏感性的影响
CD137与心肌缺血-再灌注损伤
CD13分子对非小细胞肺癌浸润Treg细胞免疫抑制的机制研究
CD133在胰腺癌中的表达及临床意义
CD137分子对衰老小鼠T细胞活化的影响
CD137和CD28分子对衰老T细胞bcl-2表达的调控
CD137和CD28分子对衰老T细胞活化的调节作用
CD133~+脐血干细胞对大肠癌SW480细胞生长、黏附及迁移的影响
CD133抗原在白血病及MDS骨髓细胞中的表达
CD13 and ROR2 Permit Isolation of Highly Enriched Cardiac Mesoderm from Differentiating Human Embryonic Stem Cells
CD133 and DNA-PK regulate MDR1 via the PI3K-or Akt-NF-kappa B pathway in multidrug-resistant glioblastoma cells in vitro
CD133(+)CD44(+) Cells Mediate in the Lung Metastasis of Osteosarcoma
CD133(+) and Nestin(+) Glioma Stem-Like Cells Reside Around CD31(+) Arterioles in Niches that Express SDF-1 alpha, CXCR4, Osteopontin and Cathepsin K
CD13 mediates phagocytosis in human monocytic cells
CD133-targeted Gene Transfer Into Long-term Repopulating Hematopoietic Stem Cells
CD133和Ki-67在骨巨细胞瘤中的表达及其临床意义
CD137 Regulates NFATc1 Expression in Mouse VSMCs through TRAF6/NF-kappa B p65 Signaling Pathway
CD137 ligand-mediated reverse signaling inhibits proliferation and induces apoptosis in non-small cell lung cancer
CD133~+卵巢癌干细胞样细胞在血管内皮细胞中的分化
CD133阳性/阴性肺癌细胞的分选、鉴定及差异基因的筛选
CD133脐血干细胞对妊娠期糖尿病的影响
CD133 Expression in Lymph Node Metastases Is Associated with Tumor Aggressiveness During Lymph Node Metastasis in Colorectal Cancer
CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like Cells
CD133 Expression Correlates with Membrane Beta-Catenin and E-Cadherin Loss from Human Hair Follicle Placodes during Morphogenesis
CD138-negative myeloma cells regulate mechanical properties of bone marrow stromal cells through SDF-1/CXCR4/AKT signaling pathway
CD133(+) melanoma subpopulation acquired resistance to caffeic acid phenethyl ester-induced apoptosis is attributed to the elevated expression of ABCB5: Significance for melanoma treatment
CD137 (4-1BB) Deficiency Reduces Atherosclerosis in Hyperlipidemic Mice
CD133(+) circulating haematopoietic progenitor cells predict for response to sorafenib plus erlotinib in non-small cell lung cancer patients
CD137 Is Required for M Cell Functional Maturation but Not Lineage Commitment
CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patients
CD138 shedding in plasma cell myeloma
CD133 expression predicts for non-response to chemotherapy in colorectal cancer
CD133(+) cells from human umbilical cord blood reduce cortical damage and promote axonal growth in neonatal rat organ co-cultures exposed to hypoxia
CD133 expression is not selective for tumor-initiating or radioresistant cell populations in the CRC cell line HCT-116
CD133+cells from medulloblastoma and PNET cell lines are more resistant to cyclopamine inhibition of the sonic hedgehog signaling pathway than CD133-cells
CD13 is a therapeutic target in human liver cancer stem cells
CD137 ligand signaling induces human monocyte to dendritic cell differentiation
CD137 enhances monocyte-ICAM-1 interactions in an E-selectin-dependent manner under flow conditions
CD133 expression is a potential prognostic indicator in intrahepatic cholangiocarcinoma
CD133 mRNA Expression and Microsatellite Instability in Colorectal Carcinoma
CD133 expression in chemo-resistant Ewing sarcoma cells
CD133, Trop-2 and alpha 2 beta 1 integrin surface receptors as markers of putative human prostate cancer stem cells
CD133, CD15/SSEA-1, CD34 or side populations do not resume tumor-initiating properties of long-term cultured cancer stem cells from human malignant glio-neuronal tumors
CD137 ligand mediates opposite effects in human and mouse NK cells and impairs NK-cell reactivity against human acute myeloid leukemia cells
CD138 and CD31 Double-Positive Cells Comprise the Functional Antibody-Secreting Plasma Cell compartment in Primate Bone Marrow
CD13/aminopeptidase N is a negative regulator of mast cell activation
CD133 does not enrich for the stem cell activity in vivo in adult mouse prostates
CD133(+) cells in pulmonary arterial hypertension
CD133 Modulate HIF-1 Expression under Hypoxia in EMT Phenotype Pancreatic Cancer Stem-Like Cells
CD133 induced tumorigenicity mice express TGF-beta receptor type II (TBRII) and embryonic liver fodrin (ELF) along with stem cell markers
CD133 promotes gallbladder carcinoma cell migration through activating Akt phosphorylation
CD133 expression may be useful as a prognostic indicator in colorectal cancer, a tool for optimizing therapy and supportive evidence for the cancer stem cell hypothesis: a meta-analysis
CD133在小儿急性白血病中的表达及临床意义
CD133在子宫内膜异位症相关卵巢癌中的表达
CD137表达与慢性乙型肝炎患者肝脏免疫病理损伤程度的相关性研究
CD133、ALDH1、LGR5在卵巢上皮癌的表达及对预后影响的相关性分析
CD133作为结肠癌HT29细胞系干细胞特异性生物标志的研究
CD133在口腔扁平苔藓和口腔鳞状细胞癌中的表达及其临床意义
CD133/prominin1 is prognostic for GBM patient's survival, but inversely correlated with cysteine cathepsins' expression in glioblastoma derived spheroids
CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway
CD133(+) Cancer Stem Cell-like Cells Derived from Uterine Carcinosarcoma (Malignant Mixed Mullerian Tumor)
CD133 expression is correlated with chemoresistance and early recurrence of gastric cancer
CD133 antisense suppresses cancer cell growth and increases sensitivity to cisplatin in vitro
CD133-positive hepatocellular carcinoma in an area endemic for hepatitis B virus infection
CD133 antigen expression in ovarian cancer
CD133 is a marker of gland-forming cells in gastric tumors and Sox17 is involved in its regulation
CD137 Is Expressed in Follicular Dendritic Cell Tumors and in Classical Hodgkin and T-Cell Lymphomas Diagnostic and Therapeutic Implications
CD137 ligand, a member of the tumor necrosis factor family, regulates immune responses via reverse signal transduction
CD133(+) cells as a therapeutic target for kidney diseases
CD133(+) Melanoma Subpopulations Contribute to Perivascular Niche Morphogenesis and Tumorigenicity through Vasculogenic Mimicry
CD133 Is a Marker of Bioenergetic Stress in Human Glioma
CD133 expression in rectal cancer after preoperative chemoradiotherapy
CD133 Is Essential for Glioblastoma Stem Cell Maintenance
CD133 expression is associated with small round blue cell tumour morphology in human central nervous system neoplasms